Highlights and Quick Summary
- Long Term Debt (Total) for the quarter ending February 28, 2023 was $87.4 Thousand (a -14.06% decrease compared to previous quarter)
- Year-over-year quarterly Long Term Debt (Total) decreased by -36.16%
- Annual Long Term Debt (Total) for 2022 was $122 Thousand (a -32.8% decrease from previous year)
- Annual Long Term Debt (Total) for 2021 was $181 Thousand (a -99.76% decrease from previous year)
- Annual Long Term Debt (Total) for 2020 was $77.1 Million (a 121.94% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long Term Debt (Total) of Organigram Holdings Inc.
Most recent Long Term Debt (Total)of OGI including historical data for past 10 years.Interactive Chart of Long Term Debt (Total) of Organigram Holdings Inc.
Organigram Holdings Inc. Long Term Debt (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $0.09 | – | – | – | – |
2022 | $0.1 | $0.12 | $0.14 | $0.15 | $0.12 |
2021 | $0.17 | $0.18 | $0.2 | $41.39 | $0.18 |
2020 | $41.14 | $77.12 | $56.45 | $0.22 | $77.12 |
2019 | $59.32 | $34.75 | $35.21 | $8.25 | $34.75 |
2018 | – | – | $75.14 | $77.33 | $77.33 |
2017 | – | – | – | – | $2.46 |
2016 | – | – | – | – | $5.47 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic